GlassScriptPhysician profile
Jason E Vickery
NPI 1386703809
$1,978.70
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,305 · 2020: $558 · 2021: $116.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $341.57 | 2019-2020 | |
| Lilly USA, LLC | $276.38 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $240.15 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $158.32 | 2019-2020 | |
| Pfizer INC. | $140.56 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $138.45 | 2019-2020 | |
| Astellas Pharma US INC | $136.94 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $87.67 | 2019 | |
| Allergan, INC. | $77.97 | 2019-2020 | |
| Glaxosmithkline, LLC. | $52.30 | 2019-2021 | |
| Amgen INC. | $51.22 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $48.74 | 2019-2020 | |
| Kyowa Kirin, INC. | $32.91 | 2020 | |
| Janssen Pharmaceuticals, INC | $31.92 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.35 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $30.34 | 2019 | |
| Avanir Pharmaceuticals, INC. | $27.68 | 2019 | |
| Mylan Specialty L.P. | $23.91 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $22.02 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $15.76 | 2019 | |
| Dexcom, INC. | $13.54 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Vickery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.